Breath Analysis Technology Shows Promise for Pneumonia Prediction
Study demonstrates OneBreath platform can diagnose and predict pneumonia onset in cardiac surgery patients through volatile organic compound detection.
Category: Uncategorized
Uncategorized
Latest
Uncategorized
Latest
Purdue, physIQ to Develop a Viral Detection Algorithm for Smartwatches
Engineers are collaborating on a smartwatch-based algorithm that could detect the early signs of viral infections, including COVID-19.
Uncategorized
Latest
New Genotyping Assay Will Allow For More Diverse Genetic Testing
Twist Bioscience Corporation has collaborated with RGC for the production of a custom NGS population genetics genotyping assay.
Clinical Chemistry
Latest
BioPorto’s Acute Kidney Injury Test Now Available to US Labs Through Roche Partnership
The collaboration marks the first major commercial step to advance adoption of ProNephro AKI across US hospital institutions.
Flow Cytometry
Latest
bioAffinity Technologies Reports 72% Monthly Jump in CyPath Lung Test Sales
Company sees back-to-back record months in June and July, reaffirms forecast of 3X year-over-year revenue growth for noninvasive lung cancer diagnostic.
Mass Spectrometry
Latest
New Database Could Improve Detection of Designer Drugs in Clinical Testing
Researchers develop computational approach to predict mass spectra for unknown psychoactive substances and their metabolites.
Immunoassay
Latest
Lateral Flow Assays Market Projected to Reach $12.1 Billion by 2030
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
Molecular Diagnostics
Latest
Predicine Submits First PMA Module to FDA for Bladder Cancer Companion Diagnostic
The urine-based NGS assay received Breakthrough Device Designation in 2022 and targets genomic alterations in cancer-associated genes.
Point-of-Care
Latest
Biolabs International Launches AI-Powered Diagnostic App for Home Testing
The app integrates rapid diagnostic testing, artificial intelligence, and telehealth capabilities, while the company's decentralized clinical trial platform aims to reduce study costs and improve data collection.